Načítá se...
Treating osteoporosis in Canada: what clinical efficacy data should be considered by policy decision makers?
SUMMARY: Using a Markov state-transition model, we estimated fractures averted with risedronate using two different types of clinical efficacy data. Summary data, as opposed to individual patient data (IPD), underestimated the number of fractures averted when applied in a specified high risk populat...
Uloženo v:
| Vydáno v: | Osteoporos Int |
|---|---|
| Hlavní autoři: | , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2009
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5101050/ https://ncbi.nlm.nih.gov/pubmed/19277810 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00198-009-0870-9 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|